We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 9,778 results
  1. Regeneration of joint surface defects by transplantation of allogeneic cartilage: application of iPS cell-derived cartilage and immunogenicity

    Background

    Because of its poor intrinsic repair capacity, articular cartilage seldom heals when damaged.

    Main body

    Regenerative treatment is expected...

    Kengo Abe, Noriyuki Tsumaki in Inflammation and Regeneration
    Article Open access 14 November 2023
  2. Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008–2020

    Background

    Transplant recipients are immunocompromised and vulnerable to develo** tuberculosis. However, active tuberculosis incidence is rapidly...

    JongHoon Hyun, Myeongjee Lee, ... Ji-Man Kang in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 03 January 2024
  3. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

    This study aimed to identify the benefits of autologous-stem cell transplantation (auto-SCT) and allogeneic-SCT (allo-SCT) in patients with...

    Dong Won Baek, Joon Ho Moon, ... Sang Kyun Sohn in Blood Cancer Journal
    Article Open access 26 June 2023
  4. “What I wanted to do was build myself back up and prepare”: qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma

    Background

    The addition of qualitative methodology to randomised controlled trials evaluating complex interventions allows better understanding of...

    Orla McCourt, Abigail Fisher, ... Kwee Yong in BMC Cancer
    Article Open access 17 April 2023
  5. Novel artificial nerve transplantation of human iPSC-derived neurite bundles enhanced nerve regeneration after peripheral nerve injury

    Background

    Severe peripheral nerve damage always requires surgical treatment. Autologous nerve transplantation is a standard treatment, but it is not...

    Takayuki Nishijima, Kentaro Okuyama, ... Narihito Nagoshi in Inflammation and Regeneration
    Article Open access 13 February 2024
  6. Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial

    Study design

    This is a phase I clinical trial.

    Objectives

    Our objective was to assess the safety and feasibility of autologous mucosal olfactory...

    Homa Zamani, Mina Soufizomorrod, ... Masoud Soleimani in Spinal Cord
    Article 09 September 2021
  7. Polydactyly-derived allogeneic chondrocyte cell-sheet transplantation with high tibial osteotomy as regenerative therapy for knee osteoarthritis

    Allogeneic cell therapies are not fully effective in treating osteoarthritis of the knee (OAK). We recently reported that transplantation of...

    Kosuke Hamahashi, Eriko Toyoda, ... Masato Sato in npj Regenerative Medicine
    Article Open access 16 December 2022
  8. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial

    Background

    Older primary central nervous system lymphoma (PCNSL) patients have an inferior prognosis compared to younger patients because available...

    Lisa K Isbell, Roswitha Uibeleisen, ... Elisabeth Schorb in BMC Cancer
    Article Open access 18 August 2023
  9. Survey of HCMV in allogenic and autologous stem cell transplantation by real-time PCR in Kermanshah, west of Iran

    Introduction

    Human Cytomegalovirus (HCMV) is the most important viral pathogen in people undergoing bone marrow transplantation (BMT). HCMV detection...

    Mehrdad Payandeh, Mohammad Hossein Zamanian, ... Mohammad Dehghannejad in Infectious Agents and Cancer
    Article Open access 02 February 2021
  10. Automating iPSC generation to enable autologous photoreceptor cell replacement therapy

    Background

    Inherited retinal degeneration is a leading cause of incurable vision loss in the developed world. While autologous iPSC mediated...

    Laura R. Bohrer, Nicholas E. Stone, ... Budd A. Tucker in Journal of Translational Medicine
    Article Open access 28 February 2023
  11. Therapeutic Strategies to Potentially Cure Multiple Sclerosis: Insights into the Mechanisms of Autologous Hematopoietic Stem Cell Transplantation

    Immune reconstitution therapies (IRTs) offer the potential to induce long-lasting remission or even permanent absence of disease activity in patients...
    Protocol 2021
  12. Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

    Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against...

    Mingchu Sun, Wenhua Jiang, ... Heng Ma in Journal of Translational Medicine
    Article Open access 25 May 2023
  13. Therapeutic potential of mitochondrial transplantation in modulating immune responses post-cardiac arrest: a narrative review

    Background

    Mitochondrial transplantation (MTx) has emerged as a novel therapeutic strategy, particularly effective in diseases characterized by...

    Tomoaki Aoki, Yusuke Endo, ... Kei Hayashida in Journal of Translational Medicine
    Article Open access 03 March 2024
  14. Tolerance and Transplantation Immunology

    In this chapter, we will first discuss about the impact and mechanisms of immunological tolerance, which is differentiated into central and...
    Carsten Carlberg, Eunike Velleuer, Ferdinand Molnár in Molecular Medicine
    Chapter 2023
  15. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

    Background

    There is paucity of data regarding outcomes of children, adolescents and young adults (CAYA) patients with non-Hodgkin lymphoma (NHL)...

    Oren Pasvolsky, Roland L. Bassett, ... Yago Nieto in BMC Cancer
    Article Open access 20 December 2023
  16. Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma

    Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or...

    Jiaying Wu, Fankai Meng, ... Yi **ao in Blood Cancer Journal
    Article Open access 15 July 2021
  17. Mitochondrial Transportation, Transplantation, and Subsequent Immune Response in Alzheimer’s Disease: An Update

    Alzheimer’s disease (AD) is a devastating neurodegenerative disease characterized by memory impairment and a progressive decline in cognitive...

    Pegah Javadpour, Fatemeh Abbaszadeh, ... Rasoul Ghasemi in Molecular Neurobiology
    Article 17 February 2024
  18. Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience

    The prognostic impact of additional copies of chromosome 1q (1q + ) on outcomes of newly-diagnosed multiple myeloma (NDMM) patients undergoing...

    Oren Pasvolsky, Sassine Ghanem, ... Muzaffar H. Qazilbash in Blood Cancer Journal
    Article Open access 10 January 2024
Did you find what you were looking for? Share feedback.